Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine and serine rich nuclear protein 2 (CSRNP2)
- Target
- CSRNP2
- Molecular classification
- Transcription factor, Other (cysteine- and serine-rich nuclear protein family)
01
Overview
Cysteine and serine rich nuclear protein 2 (CSRNP2) is a nuclear protein and a member of the CSRNP protein family, characterized by cysteine- and serine-rich domains, a basic DNA-binding domain, and a transcriptional activation domain. CSRNP2 binds the AGAGTG DNA sequence and likely serves as a transcription factor involved in gene regulation, with possible roles in apoptosis, though its physiological function remains incompletely characterized. CSRNP family members (CSRNP1, CSRNP2, CSRNP3) show redundant functions in mice. While mutations or altered expression of CSRNP2 have been tentatively linked to certain rare inherited metabolic diseases (like nephrolithiasis/osteoporosis), it is not recognized as a drug target or biomarker at this time.
- Other names
- CSRNP2AXUD2Cysteine- and serine-rich nuclear protein 2
02
Mechanism of action
Not applicable (No approved drugs target CSRNP2; therefore, mechanisms of drug action are not defined)
03
Biological functions
Transcriptional regulationPotential role in apoptosis
04
Disease associations
Other (No unequivocal disease associations; some links have been made to nephrolithiasis/osteoporosis, but the mechanistic basis and disease relevance are not established)
Beyond the preview
Go deeper on Cysteine and serine rich nuclear protein 2 (CSRNP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cysteine and serine rich nuclear protein 2 (CSRNP2).